|
Volumn 172, Issue 12, 2005, Pages 1605-
|
Combined pulmonary fibrosis and emphysema: An experimental and clinically relevant phenotype [2]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CIGARETTE SMOKE;
CYTOKINE;
NICOTINE;
SURFACTANT PROTEIN C;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR ALPHA RECEPTOR;
DNA POLYMORPHISM;
DYSPNEA;
EMPHYSEMA;
ENDOTHELIUM CELL;
EXERCISE;
FIBROSIS;
GENE OVEREXPRESSION;
GENETIC SUSCEPTIBILITY;
HUMAN;
HYPOXEMIA;
IMAGING;
INTERSTITIAL LUNG DISEASE;
LETTER;
LUNG FIBROSIS;
LUNG VOLUME;
MACROPHAGE;
MONOCYTE;
NONHUMAN;
PATHOLOGY;
PHENOTYPE;
PLASMA;
PREVALENCE;
PRIORITY JOURNAL;
PROGNOSIS;
PROMOTER REGION;
PULMONARY HYPERTENSION;
SMOKING;
TOBACCO;
TRANSGENIC MOUSE;
ANIMAL;
GENETICS;
LUNG EMPHYSEMA;
MOUSE;
NOTE;
SYNDROME;
ANIMALS;
HUMANS;
MICE;
MICE, TRANSGENIC;
PHENOTYPE;
PULMONARY EMPHYSEMA;
PULMONARY FIBROSIS;
SYNDROME;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 30444451914
PISSN: 1073449X
EISSN: 1073449X
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (34)
|
References (6)
|